SCHEMBL7418488

SCHEMBL7418488

CC(C)(CN)N1CCC(C#N)CC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24630697 0.82 KDM4E (0.33) KDM4EALDH1A1
SCHEMBL19176707 0.79 KDM4E (0.31) KDM4EALDH1A1
SCHEMBL1766240 0.77 KDM4E (0.36) KDM4EALDH1A1
SCHEMBL29214439 0.75 HTT (0.34) ALDH1A1HTT
SCHEMBL23491501 0.74 KDM4E (0.34) KDM4EALDH1A1
SCHEMBL6367927 0.73 CYP2D6 (0.37) HTT
SCHEMBL19101444 0.73
SCHEMBL27668765 0.71 HRH4 (0.31) HTT
SCHEMBL20063352 0.69 KDM4E (0.31) KDM4EALDH1A1
SCHEMBL18842659 0.69 KDM4E (0.31) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed